These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32866943)

  • 1. Renal cell carcinoma: The role of radical surgery on different patterns of local or distant recurrence.
    Di Franco G; Palmeri M; Sbrana A; Gianardi D; Furbetta N; Guadagni S; Bianchini M; Stefanini G; Adamo G; Pollina LE; Galli L; Di Candio G; Morelli L
    Surg Oncol; 2020 Dec; 35():106-113. PubMed ID: 32866943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local and Regional Recurrences of Clinically Localized Renal Cell Carcinoma after Nephrectomy: A 15 Year Institutional Experience with Prognostic Features and Oncologic Outcomes.
    Ray S; Cheaib JG; Biles MJ; Pineault KG; Johnson MH; Ged YMA; Markowski MC; Singla N; Allaf ME; Pierorazio PM
    Urology; 2021 Aug; 154():201-207. PubMed ID: 33864855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years.
    Tellini R; Antonelli A; Tardanico R; Fisogni S; Veccia A; Furlan MC; Carobbio F; Cozzoli A; Zanotelli T; Simeone C
    Clin Genitourin Cancer; 2019 Feb; 17(1):e26-e31. PubMed ID: 30266249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic resections for metastases: A twenty-year experience from a tertiary care center.
    Di Franco G; Gianardi D; Palmeri M; Furbetta N; Guadagni S; Bianchini M; Bonari F; Sbrana A; Vasile E; Pollina LE; Mosca F; Di Candio G; Morelli L
    Eur J Surg Oncol; 2020 May; 46(5):825-831. PubMed ID: 31806518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes after maximal surgical resection and intraoperative electron radiotherapy for locoregionally recurrent or locoregionally advanced primary renal cell carcinoma.
    Hallemeier CL; Choo R; Davis BJ; Pisansky TM; Gunderson LL; Leibovich BC; Haddock MG
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1938-43. PubMed ID: 21514065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-parenchyma interface and long-term oncologic outcomes after robotic tumor enucleation for sporadic renal cell carcinoma.
    Minervini A; Campi R; Di Maida F; Mari A; Montagnani I; Tellini R; Tuccio A; Siena G; Vittori G; Lapini A; Raspollini MR; Carini M
    Urol Oncol; 2018 Dec; 36(12):527.e1-527.e11. PubMed ID: 30268711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
    Lam JS; Shvarts O; Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
    J Urol; 2005 Aug; 174(2):466-72; discussion 472; quiz 801. PubMed ID: 16006866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The follow-up management of non-metastatic renal cell carcinoma: definition of a surveillance protocol.
    Antonelli A; Cozzoli A; Zani D; Zanotelli T; Nicolai M; Cunico SC; Simeone C
    BJU Int; 2007 Feb; 99(2):296-300. PubMed ID: 17326263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors.
    Santoni M; Conti A; Partelli S; Porta C; Sternberg CN; Procopio G; Bracarda S; Basso U; De Giorgi U; Derosa L; Rizzo M; Ortega C; Massari F; Iacovelli R; Milella M; Di Lorenzo G; Buti S; Cerbone L; Burattini L; Montironi R; Santini D; Falconi M; Cascinu S
    Ann Surg Oncol; 2015; 22(6):2094-100. PubMed ID: 25472645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma.
    Schrodter S; Hakenberg OW; Manseck A; Leike S; Wirth MP
    J Urol; 2002 Apr; 167(4):1630-3. PubMed ID: 11912377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal fossa recurrence after radical nephrectomy: Current management, and oncological outcomes.
    Romeo A; Garcia Marchiñena P; Jurado AM; Gueglio G
    Urol Oncol; 2020 Feb; 38(2):42.e7-42.e12. PubMed ID: 31711833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical treatment of recurrent retroperitoneal sarcoma in its different patterns: A 15-years' two-centers experience.
    Guadagni S; Peri A; Palmeri M; Furbetta N; Di Franco G; Filardo M; Comandatore A; Pollina LE; Gaeta R; Sbrana A; Galli L; Mercinelli C; Pietrabissa A; Di Candio G; Morelli L
    Surgeon; 2023 Oct; 21(5):e249-e257. PubMed ID: 36707317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic resection of local recurrence after previous radical nephrectomy for clinically localized renal-cell carcinoma: perioperative outcomes and initial observations.
    Yohannan J; Feng T; Berkowitz J; Connolly SS; Pierorazio P; Allaf ME
    J Endourol; 2010 Oct; 24(10):1609-12. PubMed ID: 20629564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.
    Petros FG; Metcalfe MJ; Yu KJ; Keskin SK; Fellman BM; Chang CM; Gu C; Tamboli P; Matin SF; Karam JA; Wood CG
    World J Urol; 2018 Jul; 36(7):1093-1101. PubMed ID: 29488096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy.
    Thomas AZ; Adibi M; Borregales LD; Hoang LN; Tamboli P; Jonasch E; Tannir NM; Matin SF; Wood CG; Karam JA
    J Urol; 2015 Aug; 194(2):316-22. PubMed ID: 25758610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Rate of Cancer Events After Partial Nephrectomy for Renal Cell Carcinoma: Clinicopathologic Analysis of 1994 Cases with Emphasis on Definition of "Recurrence".
    Bertolo R; Nicolas M; Garisto J; Magi-Galluzzi C; McKenney JK; Kaouk J
    Clin Genitourin Cancer; 2019 Jun; 17(3):209-215.e1. PubMed ID: 31000486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical management for local retroperitoneal recurrence of 33 renal cell carcinoma patients underwent radical nephrectomy].
    Huang JW; Cai W; Kong W; Zhang J; Chen YH; Huang YR
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):703-707. PubMed ID: 31550862
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
    Itano NB; Blute ML; Spotts B; Zincke H
    J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
    Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
    Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical excision of isolated renal-bed recurrence after radical nephrectomy for renal cell carcinoma.
    Sandhu SS; Symes A; A'Hern R; Sohaib SA; Eisen T; Gore M; Christmas TJ
    BJU Int; 2005 Mar; 95(4):522-5. PubMed ID: 15705072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.